VYN-202

N/A

Report date: 2025/02/20 16:31:42
NMEFirst In Class

Base Information

Drug NameVYN-202
Drug Alias NameVYN-202VYN202TAY-B2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsPlaque psoriasisPsoriasisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTay Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTay Therapeutics LtdVyne Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A